Today’s AI Top Pick: PODD

7/21/2026 · Turnaround screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · PODD82%218 resolved forecasts · 45d window · verify →

Today's pick · TurnaroundPODDBUY NOW8.6 / 107/21/2026

PODD is the cleanest multi-timeframe setup in the pool that also has clean fundamentals AND clean news. Forecasts stack up across every horizon that matters: 4h fc_mid/long +32.05% / +52.83%, 1d +55.08% / +56.98%, and even the weekly is constructive at +9.72% / +31.22% / +49.59%. Near-term_bullish is 1.0 with bullish_prob 1.0. Unlike ORCL or FUTU where the tape is being undercut by a genuine news landmine, PODD's recent headlines are neutral-to-positive (ChartMill quality-growth writeup, Calm partnership, healthcare stock to target). The fundamentals also fit the turnaround thesis without being a story stock: fwdPe 20.78, peg 0.78, ROE 23%, profit margin 10.44%, sales YoY +31.93%, EPS growth next year +24.34%, recom 1.48, target upside +40.4%. That's a real business trading at a reasonable multiple after a -41% year, not a broken pre-profit name. Debt/Eq 0.73 is manageable, shortFloat 7.04% is not crowded. The one nit is that 1d pos_in_21bar_range is 100 and 1h fc_short is -8.43%, so on the very shortest timeframe you're buying an extended bar. But on the weekly the stock is only 24.41% of the 21-bar range with a -29.37% drawdown from the weekly high, which is exactly what the 'don't chase' rule wants — daily strength emerging out of a deep weekly base. That's the ideal turnaround geometry: base broken to the upside on daily, still discounted on weekly. TODAY is the right entry because the multi-TF forecasts are aligned bullish, the weekly base gives asymmetric reward-to-risk (~30% mid-horizon upside vs. a stop under recent structure), and there is no negative news catalyst pending. Waiting for the 1h pullback the forecast implies is fine, but the daily/weekly picture argues the pullback will be shallow and the trend is already up.

Entry zone

$163-168 (current $167.41; scale in, add on any dip to $163 which aligns with the 1h fc_short -8% risk)

Stop loss

$154 (below the recent daily consolidation and about -8% from spot; invalidates the daily breakout thesis)

First target

$188-195 (roughly +12-16%, matching the 4h fc_mid +32% adjusted for volatility path and prior resistance)

Longer target

$225-240 (aligns with 1d fc_long +56% and 1wk fc_long +49.6% off the current base; also within analyst target upside +40.4%)

Risks

1d position_in_range is 100% and 1h fc_short -8.43% — expect a near-term pullback; buying spot risks a 3-5% immediate drawdown
Weekly is still in a -29.37% drawdown; a broader medtech risk-off could see it retest recent lows near $150
Debt/Eq 0.73 and 41% one-year decline mean sentiment is fragile — a guidance miss on next print could re-rate the stock down 15-20%
Insulet is single-product-line concentrated (Omnipod); competitive news from Tandem/Medtronic or CGM integrations can move it 10%+ on a headline
Institutional ownership 104.82% (over-owned) leaves less marginal buyer and higher forced-sale risk if a big holder trims

Honorable mentions

HSAIBest 'not chasing' geometry in the pool — pos_in_21bar_range 3.45% (4h) / 10.2% (1d) / 3.79% (1wk), 1d forecasts +55.78/58.47/45.55, peg 0.38, targetUpside +101.7%, 8-for-1 split announced as a positive catalyst. Held back only by an ugly 1wk fc_mid of -24.7% and stretched ps 34.68, so the risk/reward is wider than PODD.

BILICleanest multi-TF up-alignment (1d fc +30/40/33, 4h +11/30/26, near-term bullish 1.0) with a fresh $300M buyback catalyst and cheapest fwdPe (13.97) among the top names. Only reason it's #3 not #1: 4h pos_in_range 98.25% means you're chasing on the intraday timeframe, and weekly is still weak (-24.57%).

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	PODD	BUY NOW	8.6	Multi-TF up-alignment with weekly base still discounted; fundamentals clean, no news landmine.
2	HSAI	BUY NOW	7.9	Deep discount, low position in range, huge 1d/4h forecasts, split catalyst; weekly forecast weakness is the only blemish.
3	BILI	BUY PULLBACK	7.7	Strong forecasts + $300M buyback + cheapest fwdPe, but 4h pos_in_range 98% says wait for a dip.
4	CELH	BUY PULLBACK	7.2	1d fc_mid/long +57.55/+59.74 with pos_in_range only 16.84%, but 1wk fc_short is -7.87% and 20% shortFloat means chop.
5	MNDY	BUY PULLBACK	6.9	1d fc_mid +70.5% and weekly fc_long +155% look like extreme outliers; -73.7% year and 17% short float mean torque, but validate before sizing up.
6	TMDX	BUY PULLBACK	6.7	1d fc +46/57/53 and P/E 16.86 are attractive, but Evercore trimmed target to $90 and 23.68% short float adds volatility.
7	WING	BUY PULLBACK	6.6	Deep -57% year drawdown with 1d fc_mid/long +64/+71 and store-growth headline, but 1wk fc_short -0.88% wants a base first.
8	SRAD	BUY PULLBACK	6.4	1d fc +17/36/33 with peg 0.46, but 1h/1wk short forecasts are negative and price is mid-range.
9	CHWY	BUY PULLBACK	6.3	1d fc +16.84/+42.57/+44.69 and ROE 63.8%, but pos_in_range 100% on 1d — don't chase, wait for pullback.
10	KKR	BUY PULLBACK	6.2	Solid 1d fc_mid +14.9% and fwdPe 13.26, but forecasts are modest vs. peers and near-term_bullish only 0.6.
11	MLCO	BUY PULLBACK	6.1	Cheapest name (fwdPe 7.96, peg 0.35) with 1wk fc_long +53.86%, but pos_in_range 98% on 4h says wait.
12	STEP	BUY PULLBACK	6.0	Strong forecasts across TFs (1d fc +23/31/32) and near-term_bullish 1.0, but negative profit margin and ROE -750% flag accounting risk.
13	MIR	WAIT	5.7	1d fc +27/33/31 and pos_in_range 0.71%, but 1wk fc is all negative (-5/-13/-15) and P/E 167.
14	QXO	WAIT	5.6	Massive forecasts and target upside 118.8%, but negative margins, high short float 17.4%, and truncated data.
15	HLI	WAIT	5.5	1d fc +12/22/19 is decent, but 1wk forecasts all negative and recom just 2.0 (weakest analyst support).
16	ONON	WAIT	5.4	Muted forecasts across all TFs (best is 1d fc_mid +10.4%) and 1wk fc_mid -8.77%; least-broken but least-torque name.
17	KTOS	WAIT	5.2	1d fc +23/48/60 attractive, but 1wk fc catastrophic (-23/-37/-52) and P/E 271 — the model sees a bounce, not a trend.
18	SPOT	WAIT	5.1	Only 1d timeframe is bullish; 1h/4h/1wk all show negative fc_mid/long — trend deteriorating.
19	APO	WAIT	5.0	Solid analyst backing and HSBC Buy initiation, but 1wk forecasts negative across the board.
20	SE	WAIT	4.9	1d fc positive but 1h/4h fc_long -16.7%/-10.4% and CFO/insider sales are a yellow flag.
21	GRAB	WAIT	4.8	Decent 1d fc +15/25/22 but CFO sold 50k shares and CEO sold 400k — insider selling undermines the setup.
22	ARES	WAIT	4.7	bullish_prob only 0.8, 1wk fc all negative, and Oppenheimer just trimmed target to $140.
23	MELI	WAIT	4.6	Only 1d TF strong; recent 49% run has already priced in the mean reversion, peg 1.27 stretched.
24	UBER	WAIT	4.5	Peg 3.11 stretched and forecasts modest; barely met screen with perfYear -20.33%.
25	NOW	WAIT	4.4	Near-term_bullish only 0.4, 1wk fc_short -5.36%, and TheStreet flagged bearish call ahead of earnings.
26	KVYO	WAIT	4.2	Truncated forecast data, 21.6% short float, negative ROE and margins — high risk, unclear signal.
27	ORCL	AVOID	3.5	Hitting 52-week lows with $7B Wisconsin collateral risk headline; strong forecast undercut by material negative news.
28	CALX	AVOID	3.2	Just plunged on Q2 revenue miss (July 20) despite EPS beat; forecast is a bounce, not a trend recovery.
29	FUTU	AVOID	3.0	DOJ probe and class-action lawsuits (July 3) are a material landmine — do not front-run legal risk regardless of tape.
30	TOST	AVOID	2.8	Every forecast horizon negative (1h -19.66%/1wk -15.57%) plus CRO just sold 11,170 shares — broken setup.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord